Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artemether-lumefantrine for uncomplicated falciparum malaria in Eritrea
ACTRN12618001223224Phase 4Terminated
- Sponsor
- Ministry of Health
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artemether + lumefantrine in Malaria, sponsored by Ministry of Health. Primary endpoint: Percent of treatment failures. Started Sep 2017; status: terminated.
02
Drugs
artemether + lumefantrine
03
Conditions
Malaria
Beyond the preview
Go deeper on ACTRN12618001223224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618001223224.